FDAFDA · Food and drugs·Recall number D-1250-2014
XIYOUJI QINGZHI CAPSULE, 300mg, 20 count box
Published April 30, 2014 · Recall initiated: May 20, 2013
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed without an Approved NDA/ANDA: Products found to contain undeclared sibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.
What to do
Voluntary: Firm initiated · E-Mail
Recall details
- Manufacturer
- Dolphin Intertrade Corporation
- Distributor
- Nationwide
- Lot
- All Lots
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.